Olamide Olawoyin, Benjamin Press, Ankur Choksi, Nishan Sohoni, Robert Weiss, Joshua Sterling, Angela M Arlen
{"title":"Factors Associated with Short Term Outcomes After Pyeloplasty in the Pediatric Population.","authors":"Olamide Olawoyin, Benjamin Press, Ankur Choksi, Nishan Sohoni, Robert Weiss, Joshua Sterling, Angela M Arlen","doi":"10.1016/j.urology.2025.02.016","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To determine the patient and surgical factors that contribute to 30 days morbidity after pediatric pyeloplasty using a national database.</p><p><strong>Methods: </strong>This retrospective cohort study used the National Surgical Quality Improvement Program pediatrics (NSQIP) database to evaluate factors associated with 30 days post- surgical outcomes in pediatric patients who had undergone open and laparoscopic pyeloplasty between 2012-2021. Patient factors evaluated included demographics, history of prematurity (HOP), weight, and ASA classification. Surgical factors included operative time, preop labs and prior steroid use. Complications were categorized using the Clavien-Dindo (CD) classification.</p><p><strong>Results: </strong>8,221 patients met inclusion criteria. There were 528 (6.4%) readmissions within 30 days. 30 cases, 0.4% were related to obstruction. Urinary Tract Infection (UTI) was the most frequent post-operative complication (n = 232, 2.8%). Median age at the time of surgery was 23 months, 90 patients were < 30 days old at the time of surgery. Age < 23 months and HOP were associated with CD I-II (OR 1.89, p <0.01 and 5.82, p <0.05 respectively). Low weight at time of surgery was associated with CD III-V (OR 0.98, p <0.05). HOP was also associated with incidence of UTI (OR 8.09, p <0.05).</p><p><strong>Conclusion: </strong>Complications after pyeloplasty are rare and most commonly due to UTI. History of Prematurity (HOP) and low weight at the time of surgery were associated with increased complications after pyeloplasty.</p>","PeriodicalId":23415,"journal":{"name":"Urology","volume":" ","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2025-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.urology.2025.02.016","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To determine the patient and surgical factors that contribute to 30 days morbidity after pediatric pyeloplasty using a national database.
Methods: This retrospective cohort study used the National Surgical Quality Improvement Program pediatrics (NSQIP) database to evaluate factors associated with 30 days post- surgical outcomes in pediatric patients who had undergone open and laparoscopic pyeloplasty between 2012-2021. Patient factors evaluated included demographics, history of prematurity (HOP), weight, and ASA classification. Surgical factors included operative time, preop labs and prior steroid use. Complications were categorized using the Clavien-Dindo (CD) classification.
Results: 8,221 patients met inclusion criteria. There were 528 (6.4%) readmissions within 30 days. 30 cases, 0.4% were related to obstruction. Urinary Tract Infection (UTI) was the most frequent post-operative complication (n = 232, 2.8%). Median age at the time of surgery was 23 months, 90 patients were < 30 days old at the time of surgery. Age < 23 months and HOP were associated with CD I-II (OR 1.89, p <0.01 and 5.82, p <0.05 respectively). Low weight at time of surgery was associated with CD III-V (OR 0.98, p <0.05). HOP was also associated with incidence of UTI (OR 8.09, p <0.05).
Conclusion: Complications after pyeloplasty are rare and most commonly due to UTI. History of Prematurity (HOP) and low weight at the time of surgery were associated with increased complications after pyeloplasty.
期刊介绍:
Urology is a monthly, peer–reviewed journal primarily for urologists, residents, interns, nephrologists, and other specialists interested in urology
The mission of Urology®, the "Gold Journal," is to provide practical, timely, and relevant clinical and basic science information to physicians and researchers practicing the art of urology worldwide. Urology® publishes original articles relating to adult and pediatric clinical urology as well as to clinical and basic science research. Topics in Urology® include pediatrics, surgical oncology, radiology, pathology, erectile dysfunction, infertility, incontinence, transplantation, endourology, andrology, female urology, reconstructive surgery, and medical oncology, as well as relevant basic science issues. Special features include rapid communication of important timely issues, surgeon''s workshops, interesting case reports, surgical techniques, clinical and basic science review articles, guest editorials, letters to the editor, book reviews, and historical articles in urology.